Poland vs Serbia: Cause of death, by non-communicable diseases, ages 15-59, male
Poland
64.8%
in 2021
Serbia
63.8%
in 2021
Poland rank
46th
Serbia rank
48th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Poland
- Serbia
How they compare
Poland currently reports 64.8% against 63.8% in Serbia, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Serbia ahead.
Poland ranks 46th and Serbia ranks 48th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Poland | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.8% | 79.5% | 5.7% | Serbia |
| 2010s | 75.3% | 83.7% | 8.5% | Serbia |
| 2020s | 67.1% | 67.8% | 0.6% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Poland or Serbia?
- Poland, at 64.8% against 63.8% in Serbia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Poland and Serbia?
- 1.0%, with Poland ahead.
- How many years of comparable data are there for Poland and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Poland and Serbia rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Poland ranks 46th and Serbia ranks 48th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.